# Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF

> **NCT06370585** · PHASE1 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 36 (actual)

## Conditions studied

- Dry Eye Disease
- Ocular Surface Disease

## Interventions

- **DRUG:** PRO-229
- **DRUG:** Lagricel® Ofteno PF

## Key facts

- **NCT ID:** NCT06370585
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-16
- **Primary completion:** 2024-07-25
- **Final completion:** 2024-11-13
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06370585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06370585, "Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06370585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*